The randomized DYNAMIC Trial: ctDNA-guided approach towards adjuvant chemotherapy
Should we have a circulating tumor DNA (ctDNA)-guided approach towards adjuvant chemotherapy in patients with stage II colon cancer? Let Jeanne Tie, Medical Oncologist, update you on the area by the latest results from the randomized DYNAMIC trial.
Get access to the article
If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.